Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults
2024

Effectiveness of COVID-19 mRNA Vaccines Against Hospitalizations

Sample size: 10000000 publication 10 minutes Evidence: high

Author Information

Author(s): Bill K.-F. Wong, Neil A. Mabbott

Primary Institution: University of Edinburgh

Hypothesis

What is the real-world effectiveness of COVID-19 mRNA vaccines against hospitalizations in adults?

Conclusion

The Pfizer/BioNTech and Moderna mRNA vaccines provide strong protection against COVID-19 hospitalizations, but effectiveness may decrease with the Omicron variant.

Supporting Evidence

  • High vaccine effectiveness was reported for both BNT162b2 and mRNA-1273 vaccines.
  • Meta-analysis indicated pooled effectiveness estimates ranged from 84% to 86%.
  • Booster doses can restore waning effectiveness.
  • VE was lower during the prevalence of the Omicron variant.

Takeaway

The COVID-19 vaccines from Pfizer and Moderna work really well to keep people out of the hospital, but they might not work as well against some new virus types.

Methodology

A systematic review and meta-analysis of 50 studies evaluating vaccine effectiveness against COVID-19 hospitalization.

Potential Biases

Potential biases due to the exclusion of studies from underrepresented regions.

Limitations

The review had uneven geographical representation and did not account for follow-up duration variability.

Participant Demographics

Studies included adults over 18 years old, with a majority from the United States, Israel, and the United Kingdom.

Statistical Information

P-Value

<.0001

Confidence Interval

80.27–88.40

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1093/immadv/ltae011

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication